Ethicon Endo-Surgery has received Food and Drug Administration marketing clearance for a handheld version of its Mammotome minimally invasive breast-biopsy device. The new unit, called Mammotome Hand Held, will be available Sept. 20, according to the
Ethicon Endo-Surgery has received Food and Drug Administration marketing clearance for a handheld version of its Mammotome minimally invasive breast-biopsy device. The new unit, called Mammotome Hand Held, will be available Sept. 20, according to the Cincinnati-based division of Johnson & Johnson. Ethicon expects Mammotome Hand Held will be employed in physicians offices, breast care centers, and hospitals. Using ultrasound guidance, Mammotome Hand Held vacuums out suspicious tissue for examination, according to the company. The original table-mounted Mammotome has been available in the U.S. since 1995 and has been used for more than 375,000 breast biopsies.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.